Atreon Orthopedics develops the ROTIUM bioresorbable scaffold, designed to enhance tendon-to-bone healing by mimicking the extracellular matrix and promoting cellular ingrowth. This technology addresses the challenge of inadequate tissue regeneration and scar tissue formation following rotator cuff repairs, leading to improved long-term recovery outcomes.
Funding
$3.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Rotator cuff repairs often result in inadequate tendon-to-bone healing and the formation of scar tissue, leading to compromised long-term recovery and functional outcomes. Current surgical techniques struggle to fully regenerate healthy tissue at the tendon-bone interface.
Solution
Atreon Orthopedics offers the ROTIUM bioresorbable scaffold, an interpositional device designed to enhance tendon-to-bone healing in rotator cuff repairs. The ROTIUM scaffold mimics the natural extracellular matrix (ECM), providing a structure that supports cellular ingrowth and proliferation at the repair site. By wicking and holding autologous biology, the scaffold aims to create a pro-healing environment that encourages the remodeling of strong, healthy tissue integration, rather than scar tissue formation. The ROTIUM scaffold is intended to supercharge the natural phases of tendon healing and support the development of healthy tissue architecture.
Target Audience
The primary target audience includes orthopedic surgeons specializing in sports medicine and rotator cuff repairs.
Features
- Bioresorbable scaffold composed of microfibers that mimic the extracellular matrix (ECM)
- Designed to wick and hold autologous biology at the repair site
- Supports cellular ingrowth and proliferation
- Promotes remodeling of strong, healthy tissue integration
- Intended for use in conjunction with suture anchors